Wockhardt forms alliance with Sheffield Bio-Science; stock up

MUMBAI: Wockhardt has entered into global alliance with Sheffield Bio-Science for sales, marketing and distribution of recombinant insulin in cell culture markets globally. The potential in cell culture market is around $50 million, the company said in a statement to the stock exchanges.

The stock was at Rs 349, up 1.16 per cent on the NSE. It touched a high of Rs 355.95 and low of Rs 347 in trade so far.